Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


06.11.2017

3 AJR Am J Roentgenol
5 Ann Oncol
8 Ann Surg Oncol
3 BMC Cancer
1 BMJ
6 Breast Cancer
4 Breast Cancer Res Treat
1 Cancer Cell
2 Cancer Epidemiol Biomarkers Prev
3 Cancer Lett
1 Cancer Res
1 Carcinogenesis
6 Clin Breast Cancer
2 Clin Cancer Res
4 Eur J Cancer
1 Eur Radiol
2 Int J Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Natl Cancer Inst
1 J Pathol
1 J Surg Oncol
3 N Engl J Med
1 NPJ Breast Cancer
2 Oncogene
2 Oncology (Williston Park)
1 PLoS Comput Biol
7 PLoS One
2 Proc Natl Acad Sci U S A
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. DOGAN BE, Scoggins ME, Son JB, Wei W, et al
    American College of Radiology-Compliant Short Protocol Breast MRI for High-Risk Breast Cancer Screening: A Prospective Feasibility Study.
    AJR Am J Roentgenol. 2017 Nov 1:1-8. doi: 10.2214/AJR.17.18267.
    PubMed     Text format     Abstract available

  2. MONTICCIOLO DL, Helvie MA, Hendrick RE
    Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    AJR Am J Roentgenol. 2017 Nov 1:1-7. doi: 10.2214/AJR.17.18629.
    PubMed     Text format     Abstract available

  3. NEAL CH, Rahman WT, Joe AI, Noroozian M, et al
    Harms of Restrictive Risk-Based Mammographic Breast Cancer Screening.
    AJR Am J Roentgenol. 2017 Nov 1:1-7. doi: 10.2214/AJR.17.18120.
    PubMed     Text format     Abstract available


    Ann Oncol

  4. MOBUS V, Jackisch C, Lueck HJ, du Bois A, et al
    Ten-year Results of Intense Dose-dense chemotherapy show superior survival compared to a conventional schedule in High-risk Primary Breast Cancer: Final results of AGO Phase III iddEPC trial.
    Ann Oncol. 2017 Oct 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. CRISCITIELLO C, Bayar MA, Curigliano G, Symmans FW, et al
    A gene signature to predict high tumour-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple negative breast cancer.
    Ann Oncol. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. BLACKWELL K, Gascon P, Krendyukov A, Gattu S, et al
    Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase 3, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppr
    Ann Oncol. 2017 Oct 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. KOK M
    LAG-3: another brake to release in breast cancer?
    Ann Oncol. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format    

  8. CARDOSO F, Bartlett JMS, Slaets L, van Deurzen CHM, et al
    Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
    Ann Oncol. 2017 Oct 28. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  9. BRICOU A, Sakr R, Barranger E
    Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-excision Rates in Breast Cancer?
    Ann Surg Oncol. 2017 Oct 24. doi: 10.1245/s10434-017-6188.
    PubMed     Text format    

  10. KILIC N
    Reply to An Investigation Into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products for Patients with Breast Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6183.
    PubMed     Text format    

  11. WRAY CJ
    Vitamin D Levels Affect Breast Cancer Survival Rates: A Reply.
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6160.
    PubMed     Text format    

  12. CRAGUN D, Vadaparampil S, Scherr C, Pal T, et al
    Comment on "Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey".
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6190.
    PubMed     Text format    

  13. PITSINIS V, Wishart GC
    Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2017 Oct 27. doi: 10.1245/s10434-017-6186.
    PubMed     Text format    

  14. BOUGHEY JC, Hoskin TL, Welsh JL, Day CN, et al
    Using Size and Grade to Identify Women Aged >/= 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity : Letter to Editor Reply to "Sized influences nodal status in women aged >/= 70 with endocrine responsive breast can
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6158.
    PubMed     Text format    

  15. SUGIE T, Toi M
    Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 1. doi: 10.1245/s10434-017-6187.
    PubMed     Text format    

  16. KHOUBNASABJAFARI M, Ansarin K, Jouyban A
    Comments on "An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer".
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6182.
    PubMed     Text format    


    BMC Cancer

  17. GOHR K, Hamacher A, Engelke LH, Kassack MU, et al
    Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
    BMC Cancer. 2017;17:711.
    PubMed     Text format     Abstract available

  18. LANZ HL, Saleh A, Kramer B, Cairns J, et al
    Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.
    BMC Cancer. 2017;17:709.
    PubMed     Text format     Abstract available

  19. REPO H, Gurvits N, Loyttyniemi E, Nykanen M, et al
    PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival.
    BMC Cancer. 2017;17:705.
    PubMed     Text format     Abstract available


    BMJ

  20. NACHIAPPAN S, Howlett DC
    Renal transplant, previous breast cancer, and progressive breathlessness.
    BMJ. 2017;359:j4773.
    PubMed     Text format    


    Breast Cancer

  21. SHIGEMATSU H, Ozaki S, Yasui D, Zaitsu J, et al
    Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0811.
    PubMed     Text format     Abstract available

  22. HARAO M, Ando J, Kamata H, Hoshi N, et al
    Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0813.
    PubMed     Text format     Abstract available

  23. ARAKI K, Miyoshi Y
    Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
    Breast Cancer. 2017 Oct 31. doi: 10.1007/s12282-017-0812.
    PubMed     Text format     Abstract available

  24. KHPAL M, Miller JRC, Petrovic Z, Hassanally D, et al
    Local anesthetic delivery via surgical drain provides improved pain control versus direct skin infiltration following axillary node dissection for breast cancer.
    Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0810.
    PubMed     Text format     Abstract available

  25. REGEV-AVRAHAM Z, Baron-Epel O, Hammond SK, Keinan-Boker L, et al
    Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study.
    Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0809.
    PubMed     Text format     Abstract available

  26. ADHAMI M, Haghdoost AA, Sadeghi B, Malekpour Afshar R, et al
    Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Breast Cancer. 2017 Nov 3. doi: 10.1007/s12282-017-0814.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  27. PALMIERI C, Stein RC, Liu X, Hudson E, et al
    Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
    Breast Cancer Res Treat. 2017 Oct 25. doi: 10.1007/s10549-017-4539.
    PubMed     Text format     Abstract available

  28. RODRIGUEZ-WALLBERG KA, Eloranta S, Krawiec K, Lissmats A, et al
    Safety of fertility preservation in breast cancer patients in a register-based matched cohort study.
    Breast Cancer Res Treat. 2017 Nov 2. doi: 10.1007/s10549-017-4555.
    PubMed     Text format     Abstract available

  29. NGUYEN F, Pena L, Ibisch C, Loussouarn D, et al
    Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
    Breast Cancer Res Treat. 2017 Oct 30. doi: 10.1007/s10549-017-4548.
    PubMed     Text format     Abstract available

  30. RABOW M, Small R, Jow A, Majure M, et al
    The value of embedding: integrated palliative care for patients with metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Oct 30. doi: 10.1007/s10549-017-4556.
    PubMed     Text format     Abstract available


    Cancer Cell

  31. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  32. HOWELL A, Ashcroft L, Fallowfield L, Eccles DM, et al
    RAZOR: a phase II open randomized trial of screening plus goserelin and raloxifene versus screening alone in pre-menopausal women at increased risk of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Nov 2. pii: cebp.0158.2017.
    PubMed     Text format     Abstract available

  33. SHAO S, Gill AA, Zahm SH, Jatoi I, et al
    Diabetes and overall survival among breast cancer patients in the US military health system.
    Cancer Epidemiol Biomarkers Prev. 2017 Nov 2. pii: cebp.0439.2017.
    PubMed     Text format     Abstract available


    Cancer Lett

  34. LIANG S, Chen Z, Jiang G, Zhou Y, et al
    Corrigendum to "Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-kappaB/IL-6 signals" [Cancer Lett. 386 (2017) 12-23].
    Cancer Lett. 2017 Oct 30. pii: S0304-3835(17)30662.
    PubMed     Text format    

  35. KIM YJ, Sung D, Oh E, Cho Y, et al
    Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.
    Cancer Lett. 2017;412:118-130.
    PubMed     Text format     Abstract available

  36. SYNNOTT NC, Bauer MR, Madden S, Murray A, et al
    Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.
    Cancer Lett. 2017 Oct 22. pii: S0304-3835(17)30622.
    PubMed     Text format     Abstract available


    Cancer Res

  37. PATIN EC, Soulard D, Fleury S, Hassane M, et al
    Type I IFN receptor signalling controls IL-7-dependent accumulation and activity of protumoral IL-17A-producing gammadeltaT cells in breast cancer.
    Cancer Res. 2017 Oct 25. pii: canres.1416.2017.
    PubMed     Text format     Abstract available


    Carcinogenesis

  38. RENAULT AL, Mebirouk N, Cavaciuti E, Le Gal D, et al
    Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
    Carcinogenesis. 2017;38:994-1003.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  39. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    PubMed     Text format     Abstract available

  40. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    PubMed     Text format     Abstract available

  41. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    PubMed     Text format     Abstract available

  42. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    PubMed     Text format     Abstract available

  43. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    PubMed     Text format     Abstract available

  44. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  45. EVANS KW, Yuca E, Akcakanat A, Scott SM, et al
    A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
    Clin Cancer Res. 2017;23:6468-6477.
    PubMed     Text format     Abstract available

  46. HSU PY, Wu VS, Kanaya N, Petrossian K, et al
    Dual mTOR Kinases MLN0128 Inhibitor Sensitizes HR+/HER2+ Breast Cancer Patient-derived Xenografts to Trastuzumab or Fulvestrant.
    Clin Cancer Res. 2017 Oct 27. pii: clincanres.1983.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  47. PARK YH, Im SA, Kim SB, Sohn JH, et al
    Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
    Eur J Cancer. 2017;86:385-393.
    PubMed     Text format     Abstract available

  48. BIGANZOLI E, Desmedt C, Fornili M, de Azambuja E, et al
    Recurrence dynamics of breast cancer according to baseline body mass index.
    Eur J Cancer. 2017;87:10-20.
    PubMed     Text format     Abstract available

  49. MULLOOLY M, Murphy J, Gierach GL, Walsh PM, et al
    Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.
    Eur J Cancer. 2017;86:326-333.
    PubMed     Text format     Abstract available

  50. VAN MAAREN MC, van Steenbeek CD, Pharoah PDP, Witteveen A, et al
    Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population.
    Eur J Cancer. 2017;86:364-372.
    PubMed     Text format     Abstract available


    Eur Radiol

  51. MOSHINA N, Roman M, Waade GG, Sebuodegard S, et al
    Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
    Eur Radiol. 2017 Nov 2. doi: 10.1007/s00330-017-5104.
    PubMed     Text format     Abstract available


    Int J Cancer

  52. HIRKO KA, Chai B, Spiegelman D, Campos H, et al
    Erythrocyte membrane fatty acids and breast cancer risk: A prospective analysis in the Nurses' Health Study II.
    Int J Cancer. 2017 Oct 26. doi: 10.1002/ijc.31133.
    PubMed     Text format     Abstract available

  53. SCHMIDT ME, Wiskemann J, Schneeweiss A, Potthoff K, et al
    Determinants of physical, affective, and cognitive fatigue: During breast cancer therapy and 12 months follow-up.
    Int J Cancer. 2017 Oct 30. doi: 10.1002/ijc.31138.
    PubMed     Text format     Abstract available


    Int J Oncol

  54. RAMAN V, Fuentes Lorenzo JL, Stashenko EE, Levy M, et al
    Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-kappaB signaling in triple-negative breast cancer cells.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4169.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  55. BORM KJ, Oechsner M, Combs SE, Duma MN, et al
    Deep Inspiration Breath Hold Radiation Therapy in Breast Cancer: A Word of Caution on the Dose to the Axillary Lymph Node Levels.
    Int J Radiat Oncol Biol Phys. 2017 Sep 20. pii: S0360-3016(17)33923.
    PubMed     Text format     Abstract available


    J Clin Oncol

  56. HWONG AR, Mangurian C
    Improving Breast Cancer Screening and Care for Women With Severe Mental Illness.
    J Clin Oncol. 2017 Nov 2:JCO2017760462. doi: 10.1200/JCO.2017.76.0462.
    PubMed     Text format    

  57. GANZ PA, Romond EH, Cecchini RS, Rastogi P, et al
    Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Pacl
    J Clin Oncol. 2017 Oct 26:JCO2017741165. doi: 10.1200/JCO.2017.74.1165.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  58. LAMBERTINI M, Kroman N, Ameye L, Cordoba O, et al
    Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
    J Natl Cancer Inst. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pathol

  59. DUIVENVOORDEN HM, Rautela J, Edgington-Mitchell LE, Spurling A, et al
    Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    J Pathol. 2017 Oct 31. doi: 10.1002/path.4990.
    PubMed     Text format     Abstract available


    J Surg Oncol

  60. LEE S, Jung Y, Bae Y
    Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects after mastectomy in advanced or recurrent breast cancer patients: A single center experience.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24830.
    PubMed     Text format     Abstract available


    N Engl J Med

  61. OIDE T, Mitsuishi T
    Pigmented Macule - A Skin Manifestation of Invasive Breast Cancer.
    N Engl J Med. 2017;377:1777.
    PubMed     Text format    


  62. Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.
    N Engl J Med. 2017;377:1792-3.
    PubMed     Text format    

  63. NAROD S, Booth CM, Foulkes WD
    Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.
    N Engl J Med. 2017;377:1792.
    PubMed     Text format    


    NPJ Breast Cancer

  64. PEETHAMBARAM PP, Hoskin TL, Day CN, Goetz MP, et al
    Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study.
    NPJ Breast Cancer. 2017;3:41.
    PubMed     Text format     Abstract available


    Oncogene

  65. KNOPFOVA L, Biglieri E, Volodko N, Masarik M, et al
    Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  66. LANGER EM, Kendsersky ND, Daniel CJ, Kuziel GM, et al
    ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  67. TAYLOR CE, Meisel JL
    Management of Breast Cancer Therapy-Related Sexual Dysfunction.
    Oncology (Williston Park). 2017;31:726-9.
    PubMed     Text format     Abstract available

  68. REEDER-HAYES KE, Troester MA, Meyer AM
    Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'.
    Oncology (Williston Park). 2017;31:756-62.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  69. GABASOVA E, Reid J, Wernisch L
    Clusternomics: Integrative context-dependent clustering for heterogeneous datasets.
    PLoS Comput Biol. 2017;13:e1005781.
    PubMed     Text format     Abstract available


    PLoS One

  70. COIGNET MV, Zirpoli GR, Roberts MR, Khoury T, et al
    Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
    PLoS One. 2017;12:e0187205.
    PubMed     Text format     Abstract available

  71. SUNG PL, Wen KC, Chen YJ, Chao TC, et al
    The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    PLoS One. 2017;12:e0185615.
    PubMed     Text format     Abstract available

  72. REESE DE, Henderson MC, Silver M, Mulpuri R, et al
    Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50.
    PLoS One. 2017;12:e0186198.
    PubMed     Text format     Abstract available

  73. JOHANNESSEN C, Moi L, Kiselev Y, Pedersen MI, et al
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2017;12:e0186658.
    PubMed     Text format     Abstract available

  74. HENLE AM, Nassar A, Puglisi-Knutson D, Youssef B, et al
    Downregulation of TAP1 and TAP2 in early stage breast cancer.
    PLoS One. 2017;12:e0187323.
    PubMed     Text format     Abstract available

  75. LAI HW, Liu LC, Ouyang F, Yao CC, et al
    Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent(R) eBx(R) System for the management of early stage breast cancer in Taiwan.
    PLoS One. 2017;12:e0185876.
    PubMed     Text format     Abstract available

  76. PARK JM, Bae SJ, Yoon C, Lee HS, et al
    Comparison of patients with small (</=2 cm) breast cancer according to adherence to breast screening program.
    PLoS One. 2017;12:e0186988.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  77. BASUDHAR D, Glynn SA, Greer M, Somasundaram V, et al
    Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Oct 27. pii: 201709119.
    PubMed     Text format     Abstract available

  78. SANSONE P, Savini C, Kurelac I, Chang Q, et al
    Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017;114:E9066-E9075.
    PubMed     Text format     Abstract available


    Radiother Oncol

  79. ROOS CTG, van den Bogaard VAB, Greuter MJW, Vliegenthart R, et al
    Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?
    Radiother Oncol. 2017 Oct 28. pii: S0167-8140(17)32649.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: